Crescent Biopharma Inc - Company Profile
Powered by 
All the sales intelligence you need on Crescent Biopharma Inc in one solution.
- Save hours of research time with a comprehensive
Sales Intelligence Solution.
- Understand how Crescent Biopharma Inc fits into your total
addressable market and Ideal Customer Profile.
- Gain competitive edge with triggers that tell you
when and how to engage with Crescent Biopharma Inc.
Get in touch about GlobalData Company reports
Contact the team or request a demo to find out how our data can drive your business forward
Crescent Biopharma Insights
Remove risk and uncertainty, gain a competitive edge and secure actionable leads with access to company-related investigative journalist content.
A sample of Crescent Biopharma Insights data
| Headline | Published | Journalists |
|---|---|---|
| Deserunt mollit sunt Lorem laborum do id aliqua dolore | 20 Nov 2019 | Lorem |
| GlycoMimetics’ Phase III uproleselan trial in relapsed/refractory AML protocol under review to allow patients who have failed on AbbVie/Roche’s Venclexta, sources say | 14 Nov 2019 | Ayisha Sharma |
| GlycoMimetics/Pfizer's rivipansel Phase III trial in SCD may face challenges to reach statistical significance in reducing VOC recovery time due to duration variability, experts say | 11 Feb 2019 | Mariana Lenharo |
| GlycoMimetics’ planned AML Phase III GMI-1271 program would need large sample size, but adaptive design could ease way forward – experts | 25 Jan 2017 | Alaric DeArment |
Feature
Delivers exclusive investigative journalist content including breaking news and analysis ahead of market-moving events.
Benefit
Drug Insights:
- Forward-looking, nuanced, qualitative asset analysis on development, approval & market/reimbursement potential
- Material intelligence on competitors, including breaking news
- Insight on companies’ business development needs and strategies
Outsourcing Insights:
Insight on companies’ CRO and business development needs, strategies and relationships
Value
Remove risk and uncertainty
Gain a competitive edge
Secure actionable leads
Premium databases is part of our industry range of products
Have you found what you were looking for? From start-ups to market leaders, uncover what they do and how they do it.
Access more premium companies when you subscribe to Explorer